Related Experiment Video
Updated: Dec 2, 2025
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
820
Sarcopenia - Molecular mechanisms and open questions
Petra Wiedmer1, Tobias Jung1, José Pedro Castro1
1German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
Ageing Research Reviews
|November 1, 2020
Summary
Sarcopenia, a muscle-wasting syndrome from aging, causes strength loss and mobility issues. Understanding its molecular causes is key to developing effective interventions for this common condition.
Area of Science:
- Gerontology and Muscle Physiology
Background:
- Sarcopenia is characterized by progressive loss of skeletal muscle mass, quality, and strength during aging.
- This muscle wasting leads to mobility disorders, reduced quality of life, and increased risk of falls, fractures, metabolic diseases, and mortality.
Purpose of the Study:
- To review sarcopenia as a distinct muscle-wasting syndrome.
- To summarize current molecular mechanisms underlying sarcopenia development.
- To identify research gaps for future therapeutic and lifestyle interventions.
Main Methods:
- Literature review of molecular mechanisms contributing to sarcopenia.
- Analysis of hormonal, cellular, and intracellular pathways involved in muscle aging.
Main Results:
- Sarcopenia involves diverse molecular pathways including hormone function (IGF-1, Insulin), muscle fiber characteristics, neuromuscular drive, and satellite cell activity.
- Intracellular mechanisms such as proteostasis and mitochondrial dysfunction are implicated.
- Sarcopenia is distinct from other atrophic conditions.
Conclusions:
- Multiple molecular mechanisms contribute to sarcopenia, highlighting its complexity.
- Further research is needed to develop targeted lifestyle and therapeutic strategies.
- Understanding these pathways is crucial for combating age-related muscle decline.
More Related Videos
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
4.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.9K
03:03mTOR Signaling and Cancer Progression
4.3K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.3K
01:37Mitochondria
18.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
18.3K
01:26Cross-bridge Cycle
121.2K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.2K